Current early diagnostic biomarkers of prostate cancer
Prostate cancer (PCa) has become to have the highest incidence and the second mortality rate in western countries, affecting men's health to a large extent. Although prostate-specific antigen (PSA) was discovered to help diagnose the cancer in an early stage for decades, its specificity is rela...
Main Authors: | Min Qu, Shan-Cheng Ren, Ying-Hao Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-08-01
|
Series: | Asian Journal of Andrology |
Subjects: | |
Online Access: | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=4;spage=549;epage=554;aulast=Qu |
Similar Items
-
Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01) -
PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
by: Warli SM, et al.
Published: (2023-05-01) -
Prostate Specific Antigen. Current clinical application and future prospects
by: Katerina Duskova, et al.
Published: (2015-03-01) -
Review of commercially available biomarkers in the diagnosis of prostate cancer
by: Magdalena Ostrowska, et al.
Published: (2022-11-01) -
The novel prostate cancer antigen 3 (PCA3) biomarker
by: Andreas Bourdoumis, et al.
Published: (2010-12-01)